118 related articles for article (PubMed ID: 34193007)
1. The Impact of Smoking Cessation on Hospitalization and Psychiatric Medication Utilization among People with Serious Mental Illness.
Kertes J; Stein Reisner O; Grunhaus L; Neumark Y
Subst Use Misuse; 2021; 56(10):1543-1550. PubMed ID: 34193007
[No Abstract] [Full Text] [Related]
2. Comparison of Smoking Cessation Program Registration, Participation, Smoking Cessation Medication Utilization, and Abstinence Rates Between Smokers With and Without Schizophrenia, Schizo-affective Disorder, or Bipolar Disorder.
Kertes J; Stein Reisner O; Grunhaus L; Nezry R; Alcalay T; Azuri J; Neumark Y
Nicotine Tob Res; 2022 Mar; 24(5):670-678. PubMed ID: 34626108
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Perceptions and Smoking Cessation Experiences Between Smokers With and Without Serious Mental Illness in a Large Health Maintenance Organization.
Kertes J; Neumark Y; Grunhaus L; Stein-Reisner O
J Dual Diagn; 2021; 17(4):284-295. PubMed ID: 34651553
[TBL] [Abstract][Full Text] [Related]
4. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
[TBL] [Abstract][Full Text] [Related]
5. Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service.
Peckham E; Man MS; Mitchell N; Li J; Becque T; Knowles S; Bradshaw T; Planner C; Parrott S; Michie S; Shepherd C; Gilbody S
Health Technol Assess; 2015 Mar; 19(25):1-148, v-vi. PubMed ID: 25827850
[TBL] [Abstract][Full Text] [Related]
6. Time trends in access to smoking cessation support for people with depression or severe mental illness: a cohort study in English primary care.
Falcaro M; Osborn D; Hayes J; Coyle G; Couperthwaite L; Weich S; Walters KR
BMJ Open; 2021 Dec; 11(12):e048341. PubMed ID: 34862277
[TBL] [Abstract][Full Text] [Related]
7. Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental Illness.
Vilardaga R; Rizo J; Palenski PE; Mannelli P; Oliver JA; Mcclernon FJ
Nicotine Tob Res; 2020 Aug; 22(9):1533-1542. PubMed ID: 31667501
[TBL] [Abstract][Full Text] [Related]
8. Cigarette Smoking and Quitting-Related Factors Among US Adult Health Center Patients with Serious Mental Illness.
Kalkhoran S; Thorndike AN; Rigotti NA; Fung V; Baggett TP
J Gen Intern Med; 2019 Jun; 34(6):986-991. PubMed ID: 30783880
[TBL] [Abstract][Full Text] [Related]
9. The relationship between smoking cessation and binge drinking, depression, and anxiety symptoms among smokers with serious mental illness.
Hammett PJ; Lando HA; Taylor BC; Widome R; Erickson DJ; Joseph AM; Clothier B; Fu SS
Drug Alcohol Depend; 2019 Jan; 194():128-135. PubMed ID: 30439609
[TBL] [Abstract][Full Text] [Related]
10. Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial.
Gilbody S; Peckham E; Bailey D; Arundel C; Heron P; Crosland S; Fairhurst C; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C
Lancet Psychiatry; 2019 May; 6(5):379-390. PubMed ID: 30975539
[TBL] [Abstract][Full Text] [Related]
11. Serious Mental Illness and Smoking Cessation Treatment Utilization: the Role of Healthcare Providers.
Hammett PJ; Taylor BC; Lando HA; Widome R; Erickson DJ; Fu SS
J Behav Health Serv Res; 2021 Jan; 48(1):63-76. PubMed ID: 32378032
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.
Anthenelli RM; Gaffney M; Benowitz NL; West R; McRae T; Russ C; Lawrence D; St Aubin L; Krishen A; Evins AE
J Gen Intern Med; 2019 Jun; 34(6):862-870. PubMed ID: 30847828
[TBL] [Abstract][Full Text] [Related]
13. Adaptation of a sustained care cessation intervention for smokers hospitalized for psychiatric disorders: Study protocol for a randomized controlled trial.
Hecht J; Rigotti NA; Minami H; Kjome KL; Bloom EL; Kahler CW; Price LH; Levy DE; Carpenter KM; Brown RA
Contemp Clin Trials; 2019 Aug; 83():18-26. PubMed ID: 31212100
[TBL] [Abstract][Full Text] [Related]
14. Egocentric social networks and smoking among adults with serious mental illness.
Aschbrenner KA; Bobak C; Schneider EJ; Naslund JA; Brunette MF; O'Malley AJ
Transl Behav Med; 2018 Jul; 8(4):531-539. PubMed ID: 30016519
[TBL] [Abstract][Full Text] [Related]
15. Qualitative analysis of social network influences on quitting smoking among individuals with serious mental illness.
Aschbrenner KA; Naslund JA; Gill L; Hughes T; O'Malley AJ; Bartels SJ; Brunette MF
J Ment Health; 2019 Oct; 28(5):475-481. PubMed ID: 28675331
[No Abstract] [Full Text] [Related]
16. Nicotine Withdrawal, Relapse of Mental Illness, or Medication Side-Effect? Implementing a Monitoring Tool for People With Mental Illness Into Quitline Counseling.
Segan CJ; Baker AL; Turner A; Williams JM
J Dual Diagn; 2017; 13(1):60-66. PubMed ID: 28067594
[TBL] [Abstract][Full Text] [Related]
17. Mental health status of varenicline and bupropion users during a quit attempt compared to current smokers, other quitters, and non-smokers.
Shewale AR; Borse MS; Brown JD; Li C
Drug Alcohol Depend; 2015 Sep; 154():132-8. PubMed ID: 26169448
[TBL] [Abstract][Full Text] [Related]
18. Impact of smoking cessation on psychiatric inpatients treated with clozapine or olanzapine.
Cole ML; Trigoboff E; Demler TL; Opler LA
J Psychiatr Pract; 2010 Mar; 16(2):75-81. PubMed ID: 20511731
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Proactive Tobacco Cessation Treatment Outreach Among Smokers With Serious Mental Illness.
Japuntich SJ; Hammett PJ; Rogers ES; Fu S; Burgess DJ; El Shahawy O; Melzer AC; Noorbaloochi S; Krebs P; Sherman SE
Nicotine Tob Res; 2020 Aug; 22(9):1433-1438. PubMed ID: 31957794
[TBL] [Abstract][Full Text] [Related]
20. Smoking cessation treatment for individuals with comorbid diabetes and serious mental illness in an integrated health care delivery system.
Hwong AR; Schmittdiel J; Schillinger D; Newcomer JW; Essock S; Zhu Z; Dyer W; Young-Wolff KC; Mangurian C
Addict Behav; 2021 Mar; 114():106697. PubMed ID: 33129613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
